Search is Powered by Google
Cancer / Oncology News

Cancer Survival Up Thanks To Evidence-based Approaches, Says Cancer Council, Australia

Main Category: Cancer / Oncology
Article Date: 22 Aug 2008 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

New research showing a 30 per cent gain in five-year cancer survival since 1986 shows evidence-based cancer control programs are working, Cancer Council Australia said.

Speaking on Daffodil Day (22 Aug), Cancer Council Australia Chief Executive Officer, Professor Ian Olver, said the findings of a new government report* on cancer survival and prevalence send three clear messages:

- cancer detection and treatment are improving, thanks to evidence-based approaches;
- more Australians are living with cancer for longer periods and will require support; and
- lack of progress in treating some cancers underscores the ongoing need for research.

"This is the fourth report on cancer survival in Australia in 23 years, with improvements each time and an overall increase in five-year survival of around 30 per cent," Professor Olver said.

"Sixty-four per cent of Australian women and 58 per cent of men are now alive five years after a cancer diagnosis, compared with 53 and 41 per cent respectively between 1982 and 1986, with particularly good results for patients aged between 50 and 70.

"The findings reflect the effectiveness of early detection and advances in chemotherapy, radiation therapy and surgery, which are extending the lives of people diagnosed with a range of cancers."

Professor Olver said the new figures also emphasised the need for programs that provide supportive care for cancer patients and their families. "With 655,000 Australians either living with an invasive cancer or as a long-term cancer survivor, we have to pull together as a community to support individuals and their families through the many difficulties of a cancer diagnosis," he said.

"The new data also show that we have made very limited progress in treating some complex and aggressive tumours, such as those of the lung, brain, pancreas and cancers of unknown primary source, underscoring the need for more research."

Professor Olver said the report also showed cancer survival remained lower for Australians in remote areas and for those who are financially disadvantaged, "adding urgency to the need for programs and services that reduce social inequity in cancer care outcomes".

He commended Cancer Australia, the Federal Government's cancer control agency, for commissioning the valuable research.

*Cancer survival and prevalence in Australia: report commissioned by Cancer Australia, prepared by the Australian Institute of Health and Welfare

Cancer Council Australia




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Urology
ADHD Autism Diabetes

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Shocking Pictures To Appear On Cigarette Packets In UK On 1st October
27 Sep 2008
The UK's ten million Smokers may see pictures of rotting teeth, throat cancer, and indications of male impotence (erectile dysfunction) on cigarette packets they buy at the beginning of October...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...